Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David San Segundo

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Transplantation Proceedings|January 7, 2025
Strategies for Moderate-risk Delisting in Highly Sensitized PatientsCarolina Castro Hernández, Daniel de la Sierra, Mónica Renuncio-García, et al.
Journal of Clinical Medicine|October 16, 2025
Increased Eplet Mismatch Load and Reduced Immunosuppressive Exposure Elevate the Risk of Baseline Lung Allograft DysfunctionVictor M Mora, Emilio Rodrigo, Elena González-López, et al.
International Journal of Molecular Sciences|November 12, 2016
Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver DiseaseMaría Teresa Arias-Loste, Paula Iruzubieta, Ángela Puente, et al.
Biomedicines|October 28, 2023
Donor-Derived Cell-Free DNA at 1 Month after Kidney Transplantation Relates to HLA Class II Eplet Mismatch LoadElena González-López, Javier Gonzalo Ocejo-Vinyals, Mónica Renuncio-García, et al.
Transplant Immunology|November 14, 2021
Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipientsDavid San Segundo, Sandra A Guiral-Foz, Adalberto Benito-Hernández, et al.
Therapeutic Advances in Musculoskeletal Disease|May 5, 2022
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature reviewCarmen Álvarez-Reguera, Diana Prieto-Peña, Alba Herrero-Morant, et al.
Transplantation|August 2, 2014
High proportion of pretransplantation activated regulatory T cells (CD4+CD25highCD62L+CD45RO+) predicts acute rejection in kidney transplantation: results of a multicenter studyDavid San Segundo, Olga Millán, Pedro Muñoz-Cacho, et al.
Transplant Immunology|January 17, 2016
High proportion of CD95(+) and CD38(+) in cultured CD8(+) T cells predicts acute rejection and infection, respectively, in kidney recipientsEsther Mancebo, María José Castro, Luís M Allende, et al.
Journal of Clinical Medicine|January 9, 2021
Growth Differentiation Factor 15: A Biomarker with High Clinical Potential in the Evaluation of Kidney Transplant CandidatesMarina de Cos Gomez, Adalberto Benito Hernandez, Maria Teresa Garcia Unzueta, et al.
Biomedicines|August 27, 2021
Immune Assessment of BNT162b2 m-RNA-Spike Based Vaccine Response in AdultsDavid San Segundo, Alejandra Comins-Boo, Juan Irure-Ventura, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Transplantation Proceedings|January 7, 2025
Strategies for Moderate-risk Delisting in Highly Sensitized PatientsCarolina Castro Hernández, Daniel de la Sierra, Mónica Renuncio-García, et al.
Journal of Clinical Medicine|October 16, 2025
Increased Eplet Mismatch Load and Reduced Immunosuppressive Exposure Elevate the Risk of Baseline Lung Allograft DysfunctionVictor M Mora, Emilio Rodrigo, Elena González-López, et al.
International Journal of Molecular Sciences|November 12, 2016
Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver DiseaseMaría Teresa Arias-Loste, Paula Iruzubieta, Ángela Puente, et al.
Biomedicines|October 28, 2023
Donor-Derived Cell-Free DNA at 1 Month after Kidney Transplantation Relates to HLA Class II Eplet Mismatch LoadElena González-López, Javier Gonzalo Ocejo-Vinyals, Mónica Renuncio-García, et al.
Transplant Immunology|November 14, 2021
Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipientsDavid San Segundo, Sandra A Guiral-Foz, Adalberto Benito-Hernández, et al.
Therapeutic Advances in Musculoskeletal Disease|May 5, 2022
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature reviewCarmen Álvarez-Reguera, Diana Prieto-Peña, Alba Herrero-Morant, et al.
Transplantation|August 2, 2014
High proportion of pretransplantation activated regulatory T cells (CD4+CD25highCD62L+CD45RO+) predicts acute rejection in kidney transplantation: results of a multicenter studyDavid San Segundo, Olga Millán, Pedro Muñoz-Cacho, et al.
Transplant Immunology|January 17, 2016
High proportion of CD95(+) and CD38(+) in cultured CD8(+) T cells predicts acute rejection and infection, respectively, in kidney recipientsEsther Mancebo, María José Castro, Luís M Allende, et al.
Journal of Clinical Medicine|January 9, 2021
Growth Differentiation Factor 15: A Biomarker with High Clinical Potential in the Evaluation of Kidney Transplant CandidatesMarina de Cos Gomez, Adalberto Benito Hernandez, Maria Teresa Garcia Unzueta, et al.
Biomedicines|August 27, 2021
Immune Assessment of BNT162b2 m-RNA-Spike Based Vaccine Response in AdultsDavid San Segundo, Alejandra Comins-Boo, Juan Irure-Ventura, et al.
Pageof 9